161 related articles for article (PubMed ID: 30482165)
21. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
22. [Survival of patients with metastatic breast cancer according to pathological types of tumors].
Sánchez R C; Acevedo C F; Petric G M; Galindo A H; Domínguez C F; León R A; Razmilic V D; Ceballos C; Espinoza F; Navarro O ME; Oddó B D; Camus A M
Rev Med Chil; 2014 Apr; 142(4):428-35. PubMed ID: 25117032
[TBL] [Abstract][Full Text] [Related]
23. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
[TBL] [Abstract][Full Text] [Related]
24. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
26. The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
AlZaman A; Ali E; Mohamad B; Islam M; AlZaman E; AlZaman Y
Gulf J Oncolog; 2020 Jan; 1(32):19-25. PubMed ID: 32342914
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of steroid receptors and HER 2/neu in breast cancer biopsies of women living in Puerto Rico.
Colón E; Reyes JS; González Keelan C; Climent-Peris C
P R Health Sci J; 2002 Dec; 21(4):299-303. PubMed ID: 12572236
[TBL] [Abstract][Full Text] [Related]
28. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of hormonal receptor status of malignant ovarian tumors.
Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with breast cancer in Puerto Rican women.
Morales L; Alvarez-Garriga C; Matta J; Ortiz C; Vergne Y; Vargas W; Acosta H; Ramírez J; Perez-Mayoral J; Bayona M
J Epidemiol Glob Health; 2013 Dec; 3(4):205-15. PubMed ID: 24206792
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
34. Eye diseases in Puerto Rico.
Emanuelli A; Izquierdo NJ; Townsend W
P R Health Sci J; 2005 Dec; 24(4):287-90. PubMed ID: 16570525
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer survival, survival disparities, and guideline-based treatment.
Hill DA; Friend S; Lomo L; Wiggins C; Barry M; Prossnitz E; Royce M
Breast Cancer Res Treat; 2018 Jul; 170(2):405-414. PubMed ID: 29569018
[TBL] [Abstract][Full Text] [Related]
36. Histo-epidemiological profile of breast cancers among women in the Central African Republic: about 174 cases.
Balekouzou A; Yin P; Bekolo CE; Pamatika CM; Djeintote M; Nambei SW; Ba-Mpoutou B; Mandjiza DR; Shu C; Yin M; Qing T; Koffi B
BMC Cancer; 2018 Apr; 18(1):387. PubMed ID: 29621999
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological classification and traditional prognostic indicators of breast cancer.
Li J; Chen Z; Su K; Zeng J
Int J Clin Exp Pathol; 2015; 8(7):8500-5. PubMed ID: 26339424
[TBL] [Abstract][Full Text] [Related]
38. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
39. Intraocular Metastases Secondary to Breast Carcinoma Correlates With Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor.
Parrozzani R; Frizziero L; Testi I; Miglionico G; Perrini P; Pulze S; Pilotto E; Midena E
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):3944-8. PubMed ID: 27479811
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases.
Mehdi I; Monem AA; Al Bahrani B; Ramadhan FA
Gulf J Oncolog; 2014 Jan; 1(15):38-48. PubMed ID: 24610287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]